Cargando…
Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus
Whereas cortical GAD67 reduction and subsequent GABA level decrease are consistently observed in schizophrenia and depression, it remains unclear how these GABAergic abnormalities contribute to specific symptoms. We modeled cortical GAD67 reduction in mice, in which the Gad1 gene is genetically abla...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916365/ https://www.ncbi.nlm.nih.gov/pubmed/29362511 http://dx.doi.org/10.1038/npp.2017.296 |
_version_ | 1783317001127591936 |
---|---|
author | Kolata, Stefan M Nakao, Kazuhito Jeevakumar, Vivek Farmer-Alroth, Emily L Fujita, Yuko Bartley, Aundrea F Jiang, Sunny Zhihong Rompala, Gregory R Sorge, Robert E Jimenez, Dennisse V Martinowich, Keri Mateo, Yolanda Hashimoto, Kenji Dobrunz, Lynn E Nakazawa, Kazu |
author_facet | Kolata, Stefan M Nakao, Kazuhito Jeevakumar, Vivek Farmer-Alroth, Emily L Fujita, Yuko Bartley, Aundrea F Jiang, Sunny Zhihong Rompala, Gregory R Sorge, Robert E Jimenez, Dennisse V Martinowich, Keri Mateo, Yolanda Hashimoto, Kenji Dobrunz, Lynn E Nakazawa, Kazu |
author_sort | Kolata, Stefan M |
collection | PubMed |
description | Whereas cortical GAD67 reduction and subsequent GABA level decrease are consistently observed in schizophrenia and depression, it remains unclear how these GABAergic abnormalities contribute to specific symptoms. We modeled cortical GAD67 reduction in mice, in which the Gad1 gene is genetically ablated from ~50% of cortical and hippocampal interneurons. Mutant mice showed a reduction of tissue GABA in the hippocampus and cortex including mPFC, and exhibited a cluster of effort-based behavior deficits including decreased home-cage wheel running and increased immobility in both tail suspension and forced swim tests. Since saccharine preference, progressive ratio responding to food, and learned helplessness task were normal, such avolition-like behavior could not be explained by anhedonia or behavioral despair. In line with the prevailing view that dopamine in anterior cingulate cortex (ACC) plays a role in evaluating effort cost for engaging in actions, we found that tail-suspension triggered dopamine release in ACC of controls, which was severely attenuated in the mutant mice. Conversely, ACC dopamine release by progressive ratio responding to reward, during which animals were allowed to effortlessly perform the nose-poking, was not affected in mutants. These results suggest that cortical GABA reduction preferentially impairs the effort-based behavior which requires much effort with little benefit, through a deficit of ACC dopamine release triggered by high-effort cost behavior, but not by reward-seeking behavior. Collectively, a subset of negative symptoms with a reduced willingness to expend costly effort, often observed in patients with schizophrenia and depression, may be attributed to cortical GABA level reduction. |
format | Online Article Text |
id | pubmed-5916365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-59163652018-05-01 Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus Kolata, Stefan M Nakao, Kazuhito Jeevakumar, Vivek Farmer-Alroth, Emily L Fujita, Yuko Bartley, Aundrea F Jiang, Sunny Zhihong Rompala, Gregory R Sorge, Robert E Jimenez, Dennisse V Martinowich, Keri Mateo, Yolanda Hashimoto, Kenji Dobrunz, Lynn E Nakazawa, Kazu Neuropsychopharmacology Original Article Whereas cortical GAD67 reduction and subsequent GABA level decrease are consistently observed in schizophrenia and depression, it remains unclear how these GABAergic abnormalities contribute to specific symptoms. We modeled cortical GAD67 reduction in mice, in which the Gad1 gene is genetically ablated from ~50% of cortical and hippocampal interneurons. Mutant mice showed a reduction of tissue GABA in the hippocampus and cortex including mPFC, and exhibited a cluster of effort-based behavior deficits including decreased home-cage wheel running and increased immobility in both tail suspension and forced swim tests. Since saccharine preference, progressive ratio responding to food, and learned helplessness task were normal, such avolition-like behavior could not be explained by anhedonia or behavioral despair. In line with the prevailing view that dopamine in anterior cingulate cortex (ACC) plays a role in evaluating effort cost for engaging in actions, we found that tail-suspension triggered dopamine release in ACC of controls, which was severely attenuated in the mutant mice. Conversely, ACC dopamine release by progressive ratio responding to reward, during which animals were allowed to effortlessly perform the nose-poking, was not affected in mutants. These results suggest that cortical GABA reduction preferentially impairs the effort-based behavior which requires much effort with little benefit, through a deficit of ACC dopamine release triggered by high-effort cost behavior, but not by reward-seeking behavior. Collectively, a subset of negative symptoms with a reduced willingness to expend costly effort, often observed in patients with schizophrenia and depression, may be attributed to cortical GABA level reduction. Nature Publishing Group 2018-05 2018-01-24 /pmc/articles/PMC5916365/ /pubmed/29362511 http://dx.doi.org/10.1038/npp.2017.296 Text en Copyright © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Article Kolata, Stefan M Nakao, Kazuhito Jeevakumar, Vivek Farmer-Alroth, Emily L Fujita, Yuko Bartley, Aundrea F Jiang, Sunny Zhihong Rompala, Gregory R Sorge, Robert E Jimenez, Dennisse V Martinowich, Keri Mateo, Yolanda Hashimoto, Kenji Dobrunz, Lynn E Nakazawa, Kazu Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus |
title | Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus |
title_full | Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus |
title_fullStr | Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus |
title_full_unstemmed | Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus |
title_short | Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus |
title_sort | neuropsychiatric phenotypes produced by gaba reduction in mouse cortex and hippocampus |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916365/ https://www.ncbi.nlm.nih.gov/pubmed/29362511 http://dx.doi.org/10.1038/npp.2017.296 |
work_keys_str_mv | AT kolatastefanm neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT nakaokazuhito neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT jeevakumarvivek neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT farmeralrothemilyl neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT fujitayuko neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT bartleyaundreaf neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT jiangsunnyzhihong neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT rompalagregoryr neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT sorgeroberte neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT jimenezdennissev neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT martinowichkeri neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT mateoyolanda neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT hashimotokenji neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT dobrunzlynne neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus AT nakazawakazu neuropsychiatricphenotypesproducedbygabareductioninmousecortexandhippocampus |